BILLS-110hr2900rh.pdf

VerDate Aug 31 2005 03:45 Jul 12, 2007 2007 annual fiscal year 30 days later than 180 days later than 30 days 2012 fiscal year 2008 30-day fiscal year 2009 such fiscal year a fiscal year six months later than 1 year fiscal year 2007 each fiscal year later than 90 days 180-day later than 120 days 15 days 2009 fiscal years the next fiscal year October 1, 2007 fiscal year 2012 2003 October 1, 2012 later than 60 days later than one year annually fiscal year 2011 each year fiscal year 2010 the fiscal year 2 years later than 5 days 2 year one year 12-month 20 days 17 year each of fiscal years 2008 that fiscal year 90 days five years and 2011 22 year

the ‘‘Best Pharmaceuticals the ‘‘Food and Drug Ad- the ‘‘Act the ‘‘Pediatric Medical the ‘‘Administra- 16 SESSION H. R. 2900 the ‘‘Pediatric Research

502(4

United States the United States Pediatric the District of Columbia Texas Georgia Treas- CONTENTS.—A U.S. Founda- 16 States the District of Columbia Circuit Michigan Orphan Tennessee the United States of America

appro- 4 appro- 16

Cosmetic 510(k FUNDING.—The APPROPRIATIONS.—To Indian

SEC the Federal Food, Drug U.S.C. the Food and Drug Administration Congress NIH Food and Drug Administration Foundation Drug Administration the Public Health Service Act DTC Federal Food and Drugs Board Senate Health and Human Services the Federal Register Food, Drug the Food and Drug Administra- Labor GENERAL.—If the Pediatric Advisory Committee Federal Food, Drug the House of Representatives the Federal Food the Committee on Energy the Best Pharmaceuticals for Children Act Food Office the Committee on Health, Education the Best Pharmaceuticals National Institutes of Health the National Institutes of Health uct State the Food and Drug Admin- the Commissioner of Food Pediatric Advisory Committee the Commissioner of Food and Drugs Drug United the Committee on Health the Drug Safety Oversight Board Federal Register the Committee on Energy and Commerce -Udall Foundation the Food and Drug Health House Healthcare Research and Quality

Reagan mary SIBLE.—If SCHAKOWSKY MATHESON MARKEY WYNN Subparagraph BONO UPTON RUSH PALLONE ESHOO MELANCON MYRICK INSLEE TERRY GORDON HILL GENE GREEN ting BURGESS BUTTERFIELD ROSS CAPPS BARROW HOOLEY ALLEN DEGETTE FERGUSON DINGELL ENGEL WAXMAN BARTON

postmarket user fee pediatric drugs medical devices fee amendments clinical trial food drug user drug device medical device drugs sec prescription devices sec